Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery

I. Foundational Information 1. General Principles in Nutrigenomics and Nutrigenetics 2. Nutrigenomics and Nutrigenetics: Importance in Health and Diseases 3. Nutrigenomics Research: Methods and Applications

II. Role of Nutrigenomics in Healthcare 4. Role of Nutrigenomics in Diabetes Care and Prevention 5. Role of Nutrigenomics in Obesity, Hypertension and Cardiovascular Diseaseson 6. Nutrigenomics in the Management and Prevention of Wasting, Stunting and other Nutritional Disorders 7. Nutrigenomics in the Management and Prevention of Cancer 8. Nutrigenomics in the Management and Prevention of Metabolic Diseases

III. Nutrigenomics and Drug Discovery 9. Bioactive Compounds of Nutrigenomic Importance 10. Roles of Dietary Compounds in DNA methylation 11. Roles of Dietary Compounds in Histone modification 12. Dietary Compounds as Inhibitors of DNA Methyltransferases and Histone Methyltransferases 13. Role of Bioactive Compounds in Diabetes Care and Prevention 14. Role of Bioactive Compounds in Nutritional Disorders 15. Role of Bioactive Compounds in Cancer Care and Prevention 16. Role of Bioactive Compounds in Obesity, Hypertension and Cardiovascular Diseases 17. Role of Bioactive Compounds in Metabolic Diseases 18. Regulations and Ethical Considerations in Nutrigenomics Research

Genevieve Dable Tupas, MD, MMCE, FPPS, FPSECP is an Associate Professor at the Research Center, College of Medicine, Davao Medical School Foundation, Inc, Davao City, Philippines. Her research interests include natural products research, clinical epidemiology, and their translation to benefit the community. Chukwuebuka Egbuna is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. Egbuna has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited over 20 books with Elsevier, Springer, Wiley and Taylor & Francis. His most recent book is his 3 volume book on Coronavirus Drug Discovery published by Elsevier. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services. He is a reviewer and editorial board member of various journals. His primary research interests cut across biochemistry, phytochemistry, pharmacology, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.